Best Practice & Research Clinical Anaesthesiology
Volume 20, Issue 2 , Pages 285-302 , June 2006

Benefits and harms of perioperative beta-blockade

References 

  1. Freemantle N, Cleland J, Young P, et al. Beta-blockade after myocardial infarction: systematic review and metaregression analysis. BMJ. 1999;318(7200):1730–1737
  2. Houghton T, Freemantle N, Cleland JG. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials. Eur J Heart Fail. 2000;2(3):333–340
  3. MERIT-HF Study Group . Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2006
  4. Heidenreich PA, Lee TT, Massie BM. Effects of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomised clinical trials. J Am Coll Card. 1997;30(1):27–34
  5. Lechat P, Packer M, Chalon S, et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomised trials. Circulation. 1998;98(12):1184–1191
  6. Wikstrand J. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications. J Card Vasc Pharmcol. 1990;16(supplement 5):64–75
  7. Ronnevik PK. Predicting return to work after acute myocardial infarction. Significance of clinical data, exercise test variables and beta-blocker therapy. Cardiology. 1988;75(3):230–236
  8. Priebe H-J. Perioperative myocardial infarction—aetiology and prevention. Br J Anaesth. 2005;95:3–19
  9. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335(23):1713–1720
  10. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341(24):1789–1794
  11. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg. 2003;97(3):623–633
  12. Yang H, Raymer K, Butler R, et al. Metoprolol after vascular surgery (MAVS). Can J Anesth. 2004;51(supplement 1):A7
  13. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, et al. The Diabetic Postoperative Mortality and Morbidity (DIPOM) Trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J. 2004;147(4):677–683
  14. POBBLE Trial investigators . Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41:602–609
  15. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major non-cardiac surgery. N Engl Med. 2005;353:349–361
  16. Devereaux PJ, Beattie WS, Choi PT-L. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331:313–321
  17. Crystal E, Garfinkle MS, Connolly SS et al. Interventions for preventing postoperative fibrillation in patients undergoing heart surgery. The Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003611.pub2. DOI:10.10002/14651858.CD003611.pub2.
  18. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J. 2001;141(1):148–153
  19. Gilligan DM, Chan WL, Stewart R, et al. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy. Am J Cardiol. 1991;68(8):766–772
  20. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549–556
  21. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135(11):982–989
  22. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002;94(5):1052–1064
  23. Guidelines for Assessing and Managing the Perioperative Risk from Coronary Artery Disease Associated with Major Noncardiac Surgery. Ann Intern Med 1997; 127(4): 309-12.
  24. Juul AB, Wetterslev J, Gluud C, et al. Randomized, blinded trial on perioperative metoprolol vs. placebo for diabetic patients undergoing major noncardiac surgery. Circulation. 2005;111:1725
  25. Ferguson TB, Commbs LP, Peterson ED. Preoperative β-Blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287(17):2221–2227
  26. Ten Broecke PWC, De Hert SG, Mertens E, et al. Effect of preoperative β-Blockade on perioperative mortality in coronary surgery. Br J Anaesth. 2003;90:27–31
  27. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999;88(3):477–482
  28. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology. 1998;88(1):7–17
  29. Stone JG, Foex P, Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology. 1988;68(4):495–500
  30. Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57(1):37–44
  31. Rabbani R, Topol EJ. Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res. 1999;41(2):402–417
  32. Yeager RA, Moneta GL, Edwards JM, et al. Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. Arch Surg. 1995;130(8):869–872
  33. Guvendik L, Davies M, Parker DJ. Oral beta-blockade with hypothermic potassium cardioplegia in cardiac surgery: is there an additive protective effect?. Thor Cardiovasc Surg. 1986;34(1):25–29
  34. Cork RC, Kramer TH, Dreiscmeier B, et al. The effect of esmolol given during cardiopulmonary bypass. Anesth Analg. 1995;81(2):429–430
  35. Kuhn-Regnier F, Natour E, Dhein S, et al. beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardio Thor Surg. 1999;15:67–74
  36. Plosker GL, Clissold SP. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease. Drugs. 1992;43(3):382–414
  37. Sandberg A, Abrahamsson B, Svenheden A, et al. Steady-state bioavailability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing. Pharm Res. 1993;10(1):28–34
  38. Wieselgren I, Lundborg P, Sandberg A, et al. Pharmakokinetic and pharmakodynamic evaluation of metoprolol controlled release (CR/Zok) 50mg in young subjects. J Clin Pharmacol. 1990;30(2):28–32
  39. Omvik P, Leer J, Istad H, Westergren . Equal efficacy and improved tolerability with 50 mg controlled-release metoprolol compared with 100 mg conventional metoprolol in hypertensive patients. Am J Ther. 1994;1(1):65–73
  40. Poole-Wilson PA, Swedberg K, Cleland JGF, for the COMET Investigators , et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7–13
  41. Juul AB, Wetterslev J, Kofoed-Enevoldsen A. Long-term postoperative mortality in diabetic patients undergoing major non-cardiac surgery. Eur J Anaesthesiol. 2004;21(7):523–529
  42. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology. 1999;91(6):1674–1686
  43. Davies MJ, Dysart RH, Silbert BS, et al. Prevention of tachycardia with atenolol pretreatment for carotid endarterectomy under cervical plexus blockade. Anaesth Intensive Care. 1992;20(2):161–164
  44. Bayliff CD, Massel DR, Inculet RI, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thor Surg. 1999;67(1):182–186
  45. Jakobsen CJ, Bille S, Ahlburg P, et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothor Vasc Anesth. 1997;11(6):746–751
  46. Pasternack PF, Grossi EA, Baumann FG, et al. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg. 1989;158(2):113–116
  47. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1998;352(9128):609–613
  48. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408–412
  49. Pasternack PF, Imparato AM, Baumann FG, et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation. 1987;76(3 Pt 2):III1–III7
  50. Magnusson J, Thulin T, Werner O, et al. Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. Br J Anaesth. 1986;58(3):251–260
  51. Cucchiara RF, Benefiel DJ, Matteo RS, et al. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology. 1986;65(5):528–531
  52. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326:219
  53. Ioannidis, JPA. Why most published research findings are false. PLoS Medicine www.plosmedicine.org. 2005;8:e124.
  54. Als-Nielsen B, Chen W, Gluud LL, et al. Are trial size and quality associated with treatment effects in randomised trials? Observational study of 523 randomised trials. The 12th International Cochrane Colloquium. 2004;102–103
  55. Sackett D, Haynes R, Tugwell P. Deciding on the best therapy. In: Clinical Epidemiology: a Basic Science for clinical Medicine. Boston, MA: Little Brown; 1985;p. 171–197
  56. Frishman W, Cheng A. Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors. Am Heart J. 1999;137(4):25–34
  57. Devereaux PJ, Yusuf S, Yang H, et al. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?. CMAJ. 2004;171(3):245–247
  58. Devereaux PJ, Leslie K, Yang H. The effect of perioperative beta-blockers on patients undergoing noncardiac surgery—is the answer in?. Can J Anaesth. 2004;51(8):749–755
  59. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses using actual information size (I). Clin Trials. 2005;2(supplement 1):32–33
  60. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses considering adequacy of allocation concealment (II). Clin Trials. 2005;2(supplement 1):61–62
  61. Thorlund K, Wetterslev J, Brok J, Gluud C. Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses considering heterogeneity and trial weight (III). Clin Trials. 2005;2(supplement 1):62;Abstract P36
  62. Leslie K, Devereaux PJ. A large trial is vital to prove perioperative beta-blockade effectiveness and safety before widespread use. Anesthesiology. 2004;101(3):803–806

PII: S1521-6896(05)00079-0

doi: 10.1016/j.bpa.2005.10.006

Best Practice & Research Clinical Anaesthesiology
Volume 20, Issue 2 , Pages 285-302 , June 2006

Article Tools

* Image Usage & Resolution